Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05589857

A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
5 Years – 15 Years
Healthy volunteers
Not accepted

Summary

Tto learn if playing an augmented reality game called SpellBound can reduce pain and the need for opioids in young patients following surgery.

Detailed description

Primary Objective: To assess the efficacy of SpellBound's AR-enabled scavenger hunt to reduce the rate of additional inpatient opioid use in pediatric cancer patients who are chronic/tolerant opioid users undergoing surgery compared to a control non-AR game in a randomized controlled trial. Secondary Objectives: To assess the impact of AR versus non-AR control technology in pediatric oncology patients, including: * Inpatient opioid use * Average daily inpatient pain score * Number of opioid requests during hospital stay * Inpatient PedsQL (quality of life) questionnaire score * Ambulation/"out of bed" movement * Number days to discharge-ready status * Patient experience assessed by satisfaction scores on questionnaire designed by MD Anderson Cancer Center Child Life team * Outpatient opioid use reported at 30, 60, 90 days. * Outpatient pain scores reported at 30, 60, 90 days * Outpatient PedsQL scores reported at 30, 60, and 90 days * Potential adverse events related to the use of AR (i.e., falls).

Conditions

Interventions

TypeNameDescription
DEVICEIPADParticipants will play a game using the iPad's standard camera, which will show you your hospital room and the decal/stickers s as they appear in the real world.
DEVICEAugmented RealityParticipants will play a game through (device camera and application) that add virtual or digital characters and items that let participants view the real world.

Timeline

Start date
2022-10-25
Primary completion
2024-05-09
Completion
2024-05-09
First posted
2022-10-21
Last updated
2024-10-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05589857. Inclusion in this directory is not an endorsement.